111 related articles for article (PubMed ID: 17454554)
1. Identification of urinary metabolites of orally administered N,N-dimethyl-p-toluidine in male F344 rats.
Kim NC; Ghanbari K; Kracko DA; Weber WM; McDonald JD; Dix KJ
J Toxicol Environ Health A; 2007 May; 70(10):781-8. PubMed ID: 17454554
[TBL] [Abstract][Full Text] [Related]
2. Disposition of [14C]N,N-dimethyl-p-toluidine in F344 rats and B6C3F1 mice.
Dix KJ; Ghanbari K; Hedtke-Weber BM
J Toxicol Environ Health A; 2007 May; 70(10):789-98. PubMed ID: 17454555
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of citral, an alpha,beta-unsaturated aldehyde, in male F344 rats.
Diliberto JJ; Srinivas P; Overstreet D; Usha G; Burka LT; Birnbaum LS
Drug Metab Dispos; 1990; 18(6):866-75. PubMed ID: 1981530
[TBL] [Abstract][Full Text] [Related]
4. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
[TBL] [Abstract][Full Text] [Related]
5. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
[TBL] [Abstract][Full Text] [Related]
6. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
[TBL] [Abstract][Full Text] [Related]
7. Hepatic transcriptomic alterations for N,N-dimethyl-p-toluidine (DMPT) and p-toluidine after 5-day exposure in rats.
Dunnick JK; Shockley KR; Morgan DL; Brix A; Travlos GS; Gerrish K; Michael Sanders J; Ton TV; Pandiri AR
Arch Toxicol; 2017 Apr; 91(4):1685-1696. PubMed ID: 27638505
[TBL] [Abstract][Full Text] [Related]
8. In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatization.
Yergey JA; Trimble LA; Silva J; Chauret N; Li C; Therien M; Grimm E; Nicoll-Griffith DA
Drug Metab Dispos; 2001 May; 29(5):638-44. PubMed ID: 11302928
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of tramadol and its main metabolites in horse plasma by high-performance liquid chromatography/fluorescence and liquid chromatography/electrospray ionization tandem mass spectrometry techniques.
De Leo M; Giorgi M; Saccomanni G; Manera C; Braca A
Rapid Commun Mass Spectrom; 2009 Jan; 23(2):228-36. PubMed ID: 19072864
[TBL] [Abstract][Full Text] [Related]
10. Qualitative and quantitative influences of ortho chlorine substituents on the microsomal metabolism of 4-toluidines.
Tyrakowska B; Boeren S; Geurtsen B; Rietjens IM
Drug Metab Dispos; 1993; 21(3):508-19. PubMed ID: 8100509
[TBL] [Abstract][Full Text] [Related]
11. Purification and 1H NMR spectroscopic characterization of phase II metabolites of tolfenamic acid.
Sidelmann UG; Christiansen E; Krogh L; Cornett C; Tjørnelund J; Hansen SH
Drug Metab Dispos; 1997 Jun; 25(6):725-31. PubMed ID: 9193874
[TBL] [Abstract][Full Text] [Related]
12. Plasma elimination and urinary excretion of methapyrilene in the rat.
Kelly DW; Holder CL; Korfmacher WA; Slikker W
Drug Metab Dispos; 1990; 18(6):1018-24. PubMed ID: 1981507
[TBL] [Abstract][Full Text] [Related]
13. Isolation and identification of urinary metabolites of porfiromycin in dogs and humans.
Lang W; Mao J; Doyle TW; Almassian B
Drug Metab Dispos; 2000 Aug; 28(8):899-904. PubMed ID: 10901698
[TBL] [Abstract][Full Text] [Related]
14. A synthetic approach to the generation of quercetin sulfates and the detection of quercetin 3'-O-sulfate as a urinary metabolite in the rat.
Jones DJ; Jukes-Jones R; Verschoyle RD; Farmer PB; Gescher A
Bioorg Med Chem; 2005 Dec; 13(24):6727-31. PubMed ID: 16105739
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the urinary metabolites of merbarone in cancer patients.
Supko JG; Malspeis L
Drug Metab Dispos; 1991; 19(1):263-73. PubMed ID: 1673412
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation of 12C- and 2-13C-labeled methyl tert-butyl ether, ethyl tert-butyl ether, and tert-butyl alcohol in rats: identification of metabolites in urine by 13C nuclear magnetic resonance and gas chromatography/mass spectrometry.
Bernauer U; Amberg A; Scheutzow D; Dekant W
Chem Res Toxicol; 1998 Jun; 11(6):651-8. PubMed ID: 9625733
[TBL] [Abstract][Full Text] [Related]
17. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
[TBL] [Abstract][Full Text] [Related]
18. [Study on the phase II metabolites of phenoprolamine hydrochloride in rat bile by LC/DAD/MSD].
Ding L; Zhang ZX; Ni PZ; Wang GJ; An DK
Yao Xue Xue Bao; 2001 Jun; 36(6):440-3. PubMed ID: 12585129
[TBL] [Abstract][Full Text] [Related]
19. Identification of key metabolites of tectorigenin in rat urine by HPLC-MS(n).
Zhang WD; Yang XL; ; Cao J; Li P; Yang ZL
Biomed Chromatogr; 2009 Feb; 23(2):219-21. PubMed ID: 18850580
[TBL] [Abstract][Full Text] [Related]
20. Identification of metabolites of octamethylcyclotetrasiloxane (D(4)) in rat urine.
Varaprath S; Salyers KL; Plotzke KP; Nanavati S
Drug Metab Dispos; 1999 Nov; 27(11):1267-73. PubMed ID: 10534311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
